Pharmaceutical and biotech companies rely on Arnold & Porter‘s ’precise knowledge’ of the life sciences sector for regulatory advice, litigation and investigations involving medical products and devices, clinical trials and digital health products. The firm is also well-placed to advise on transactions, ranging from M&A to partnerships and licensing, as well as on product liability claims and inquiries. The team is led by the ‘outstanding’ Adela Williams, who draws on her medical background to advise on regulations related to clinical trials, marketing authorisations, pharmacovigilance and advertising. Jackie Mulryne handles regulatory, policy and compliance advice, with a focus on digital health. Beatriz San Martin focuses on patents, SPC and other IP rights, while the ’excellent’ Libby Amos-Stone and Eleri Abreo handle regulatory advice and litigation. Ewan Townsend, recognised for his sector knowledge, advises on commercial transactions relating to the development, exploitation, and commercialisation of medicinal products. Ian Dodds-Smith is no longer at the firm.
Legal 500 redaktioneller Kommentar

Auszeichnungen

Mandantenzufriedenheit: NPS ®

Anwält*innen

Hall of Fame

Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.

Adela Williams
Adela Williams
Next Generation Partners

Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.

Jacqueline Mulryne
Jacqueline Mulryne
Leading associates

Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.

Libby Amos-Stone
Libby Amos-Stone
Eleri Abreo
Eleri Abreo
Praxisleitung

Adela Williams

Weitere Kernanwält*innen

Jackie Mulryne; Libby Amos-Stone; Eleri Abreo; Ewan Townsend; Jeremy Willcocks; Tom Wilson